Company intelligence / Profile preview

Manus Bio

Boston, Massachusetts, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Manus Bio has successfully commercialized several bio-based alternatives to traditional ingredients using its synthetic biology cell factory platform. Notable products include bio-based sweeteners (BioStevia/Reb M), nootkatone, valencene, and other natural flavor/fragrance compounds. The company partners with major industry players like Tate & Lyle and Givaudan to bring these sustainable ingredients to market at scale.

Modalities: Microbial fermentationSynthetic biology platform (cell factory engineering)
Industry: Non-Drug Biotech

Partnerships

Tate & Lyle ("The Natural Sweetener Alliance" – commercialization of Reb M)Givaudan (development/manufacture of nootkatone/valencene)

Beyond the preview

Go deeper on Manus Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Manus Bio.

Explore the full profile